December 14, 2018

Around the nation: Kaleo releases $178 generic version of its naloxone injector

Daily Briefing

    The move comes about a month after the drugmaker was criticized for raising the price of its brand-name naloxone injector from $575 to $4,100 over four years, in today's bite-sized hospital and health industry news from Arkansas, Illinois, and Washington.

    • Arkansas: Arkansas officials on Wednesday announced they will establish a helpline for Medicaid beneficiaries in the state to report that they've complied with the state's new work requirement. Beneficiaries in the state as of June are required to work 80 hours each month, with some exceptions, in order to maintain coverage under Medicaid (Demillo, AP/Sacramento Bee, 12/12).

    • Illinois: McDonald's on Tuesday announced that it plans to reduce the use of antibiotics in its beef, addressing concerns that the use of antibiotics in food could contribute to antibiotic resistance in humans. McDonald's is the largest beef purchaser in the world, and the move may set a new standard for livestock producers, according to Reuters (Reuters/New York Times, 12/11).

    • Washington: Drugmaker Kaleo has announced it will be releasing a generic version of its overdose-reversing automated naloxone injector, which will cost $178. The drugmaker in recent months was investigated by the Senate's Permanent Subcommittee on Investigations as well as CBS' "60 Minutes" after it raised the price of its brand-name naloxone injector from $575 to $4,100 over four years (Facher, STAT News, 12/12).

    Learn 5 ways to control the flow of drug expenditures

    Prescription drug expenditures are the fastest growing component of health care spending. And while reducing unwarranted prescribing variation is the single biggest improvement opportunity, there are several other near-term chances to reduce spending and grow revenues.

    Download Now

    X
    Cookies help us improve your website experience. By using our website, you agree to our use of cookies.